Gisele B. Colleoni

Sao Paulo, SP 04025002, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Sarcopenia in independent oldest-old individuals treated for diabetes, with or without metformin: a case-control study.

Sarcopenia in independent oldest-old individuals treated for diabetes, with or without metformin: a case-control study.

Journal: Acta diabetologica

Published: September 19, 2024

May critical molecular cross-talk between indoleamine 2,3-dioxygenase (IDO) and arginase during human aging be targets for immunosenescence control?

May critical molecular cross-talk between indoleamine 2,3-dioxygenase (IDO) and arginase during human aging be targets for immunosenescence control?

Journal: Immunity & ageing : I & A

Published: May 10, 2021

miRNA profile and disease severity in patients with sickle cell anemia.

miRNA profile and disease severity in patients with sickle cell anemia.

Journal: Annals of hematology

Published: December 11, 2020

Biochemical phenotyping of multiple myeloma patients at diagnosis reveals a disorder of mitochondrial complexes I and II and a Hartnup-like disturbance as underlying conditions, also influencing different stages of the disease.

Biochemical phenotyping of multiple myeloma patients at diagnosis reveals a disorder of mitochondrial complexes I and II and a Hartnup-like disturbance as underlying conditions, also influencing different stages of the disease.

Journal: Scientific reports

Published: June 12, 2020

Single nucleotide variants in immune-response genes and the tumor microenvironment composition predict progression of mantle cell lymphoma.

Single nucleotide variants in immune-response genes and the tumor microenvironment composition predict progression of mantle cell lymphoma.

Journal: BMC cancer

Published: May 18, 2020

Tumor Microenvironment Proteomics: Lessons From Multiple Myeloma.

Tumor Microenvironment Proteomics: Lessons From Multiple Myeloma.

Journal: Frontiers in oncology

Published: May 18, 2020

Single-nucleotide variants in TGFB1, TGFBR2, IL17A, and IL17F immune response genes contribute to follicular lymphoma susceptibility and aggressiveness.

Single-nucleotide variants in TGFB1, TGFBR2, IL17A, and IL17F immune response genes contribute to follicular lymphoma susceptibility and aggressiveness.

Journal: Blood cancer journal

Published: May 05, 2020

An integrative microenvironment approach for follicular lymphoma: roles of inflammatory cell subsets and immune-response polymorphisms on disease clinical course.

An integrative microenvironment approach for follicular lymphoma: roles of inflammatory cell subsets and immune-response polymorphisms on disease clinical course.

Journal: Oncotarget

Published: March 11, 2020

Sequential combination of bortezomib and WEE1 inhibitor, MK-1775, induced apoptosis in multiple myeloma cell lines.

Sequential combination of bortezomib and WEE1 inhibitor, MK-1775, induced apoptosis in multiple myeloma cell lines.

Journal: Biochemical and biophysical research communications

Published: August 26, 2019

Transcriptome Analysis of Mesenchymal Stem Cells from Multiple Myeloma Patients Reveals Downregulation of Genes Involved in Cell Cycle Progression, Immune Response, and Bone Metabolism.

Transcriptome Analysis of Mesenchymal Stem Cells from Multiple Myeloma Patients Reveals Downregulation of Genes Involved in Cell Cycle Progression, Immune Response, and Bone Metabolism.

Journal: Scientific reports

Published: August 23, 2018

Targeting the polarization of tumor-associated macrophages and modulating mir-155 expression might be a new approach to treat diffuse large B-cell lymphoma of the elderly.

Targeting the polarization of tumor-associated macrophages and modulating mir-155 expression might be a new approach to treat diffuse large B-cell lymphoma of the elderly.

Journal: Cancer immunology, immunotherapy : CII

Published: May 06, 2018

Proteasome and heat shock protein 70 (HSP70) inhibitors as therapeutic alternative in multiple myeloma.

Proteasome and heat shock protein 70 (HSP70) inhibitors as therapeutic alternative in multiple myeloma.

Journal: Oncotarget

Published: May 04, 2017

Showing 1-12 of 20

Last Updated: 09/26/2026